vs JANE

Journal Recommender vs JANE

JANE — the Journal/Author Name Estimator — has been the default journal finder for biomedical researchers since 2007. Our Journal Recommender solves the same problem across every discipline, and adds the metadata layer JANE never had: tier, open-access status, citation rate, and a predatory-journal flag. Here is the honest breakdown.

Biomedicine (MEDLINE)
JANE's domain
All disciplines
Our domain
1,214
Venues we index
Ours only
Predatory flag

What JANE is best at

JANE, built by the Biosemantics Group at Erasmus MC, is a genuinely useful tool and deserves its longevity. Its strength is depth in one domain: it matches your title and abstract against the whole of MEDLINE, so for biomedical and life-sciences papers its coverage of relevant journals is exhaustive. It is free, fast, requires no account, and also estimates potential authors and related articles — useful for finding reviewers or collaborators.

If your paper is squarely biomedical and you want the widest possible MEDLINE-backed set of candidate journals, JANE is a strong tool and we will happily point you to it.

Where the Journal Recommender is different

Three differences that matter when you are actually deciding where to submit:

  • All disciplines, not just biomedicine. JANE is built on MEDLINE, so it is thin-to-absent for engineering, computer science, the physical sciences, social science, and the humanities. Our recommender runs on a 33,976-paper library spanning ten disciplines, so an engineering or CS paper gets a real shortlist, not an empty one.
  • A predatory-journal flag. JANE returns matching journals with no safety signal. Every candidate in our results is cross-referenced against a snapshot of Beall's List plus a name-pattern heuristic — flagged venues still appear (your choice), but with an inline warning and a link to the evidence.
  • The metadata layer. For each journal we show six fixed chips: open-access status, 2-year citation rate, tier, field profile, publisher, and the predatory flag. JANE shows you the journal name and the matching articles; we show you whether the journal is one you should actually trust.

When JANE is the better fit

We will point you at JANE when these are your needs:

  • A strictly biomedical or clinical paper where MEDLINE-scale journal coverage is the priority.
  • You also want an author estimate — JANE suggests potential authors / reviewers working in the area.
  • You want the related-articles view to sanity-check that your topic is framed the way the field frames it.
  • You are deliberately cross-checking: running both tools and comparing the overlap is a perfectly good strategy.

When the Journal Recommender is the better fit

Our recommender is the right pick when:

  • Your paper is outside biomedicine — engineering, CS, physics, environmental science, social science, economics, humanities.
  • You want to avoid predatory venues and need that flagged explicitly, not left for you to discover later.
  • You care about open access and want to filter to OA-only journals in one click.
  • You want tier and citation-rate context to weigh ambition against acceptance odds.
  • You want the recommendation to show its work — the specific similar papers that drove each match.

Used together

For a biomedical paper, the strongest workflow is to run both. Use JANE for the exhaustive MEDLINE-backed candidate list and the author estimate. Then run the same title and abstract through our Journal Recommender to layer on the safety and metadata signal — the predatory flag, the tier, the open-access status, the citation rate — across the candidates JANE surfaced. The two tools answer adjacent halves of the same question: JANE answers "which journals publish work like mine?" and our recommender answers "and which of those should I actually trust and target?"

For a non-biomedical paper, JANE will not have the coverage — our recommender is the one to use.

Frequently asked questions

Yes — unlimited and free, no signup. It's bundled into our free Pre-Check tool. Because it runs on a local index with no LLM call, every search costs us effectively nothing, so there's no rate-limiting and no upsell on the recommender itself.
Run the free Journal RecommenderRead the engineering blog

Command palette

Jump anywhere, run any action.